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Endothelial cells produce various factors that regulate vascular tone, vascular permeability, angiogenesis, and inflammatory responses. The
dysfunction of endothelial cells is believed to be the major culprit in various cardiovascular diseases, including hypertension, atherosclerosis, heart
and renal failure, coronary syndrome, thrombosis, and diabetes. Endothelial cells express multiple transient receptor potential (TRP) channel
isoforms, the activity of which serves to modulate cytosolic Ca2+ levels ([Ca2+]i) and regulate membrane potential, both of which affect various
physiological processes. The malfunction and dysregulation of TRP channels is associated with endothelial dysfunction, which is reflected by
decreased nitric oxide (NO) bioavailability, inappropriate regulation of vascular smooth muscle tonicity, endothelial barrier dysfunction, increased
oxidative damage, impaired anti-thrombogenic properties, and perturbed angiogenic competence. Evidence suggests that dysregulation of TRPC4
and -C1 results in vascular endothelial barrier dysfunction; malfunction of TRPP1 and -P2 impairs endothelial NO synthase; the reduced
expression or activity of TRPC4 and -V1 impairs agonist-induced vascular relaxation; the decreased activity of TRPV4 reduces flow-induced
vascular responses; and the activity of TRPC3 and -C4 is associated with oxidative stress-induced endothelial damage. In this review, we present a
comprehensive summary of the literature on the role of TRP channels in endothelial cells, with an emphasis on endothelial dysfunction.
© 2007 Elsevier B.V. All rights reserved.1. Endothelial function and dysfunction
The endothelium, which lines the blood vessels of vascular
trees, is not an inert barrier but rather a highly active cell layer
that is involved in a variety of physiological and pathophysio-
logical processes. Endothelial cells participate in the regulation
of vascular tone, coagulation and fibribolysis, vascular
inflammatory reactions, and blood vessel formation [1]. As
with any other organ, the endothelium is subject to dysfunction
and failure. Endothelial dysfunction can be broadly defined as
disturbance of endothelial cell function that is induced by
diverse intrinsic and extrinsic factors. Such dysfunction is
reflected by decreased nitric oxide (NO) bioavailability,
inappropriate regulation of vascular smooth muscle tonicity,
impaired antithrombogenic properties, and perturbed angio-
genic competence [2–4]. These changes are the genesis of⁎ Corresponding author. Department of Physiology, Faculty of Medicine, The
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doi:10.1016/j.bbadis.2007.02.013various cardiovascular pathologies, such as hypertension and
atherosclerosis [2–4]. In humans, endothelial dysfunction can
be assessed biochemically by dosing different markers in the
blood, including adhesion molecules, cytokines, prostanoids,
and nitrites and nitrates [2]. Endothelial dysfunction can also be
assessed functionally through the measurement of arterial
stiffness, intima-to-media thickness ratio, endothelium-depen-
dent dilation in the arteries, or changes in blood flow in forearm,
coronary, or peripheral circulation in response to agonists [2].
2. TRPs in endothelial cells
The TRP channels are a group of cation channels that func-
tion as cellular sensors for various internal and external stimuli
[5]. Among the 28 unique mammalian TRP channel isoforms
that have been identified, at least 19 (all of the TRPC; TRPV1,
-V2, and -V4; all of the TRPM except -M5; and TRPP1 and -P2)
are expressed in vascular endothelial cells [6]. These channels
regulate two vital parameters in endothelial cells: [Ca2+]i and
cell membrane potential. In terms of the first parameter, all TRP
channels, except for TRPM4 and -M5, are Ca2+-permeable, and
Table 1
TRP channels in vascular cells: activation mechanisms, its linkage to vascular function and dysfunction
Channel Chromosome Activation mechanisms Functions and diseases
TRPC1 3q22–3q24 Thrombin [14,15], bFGF [26] store depletion
[14,42], stretch [57]
Endothelial barrier dysfunction [14,15,16], intimal thickening
and atherosclerosis [70], angiogenesis [7,26,27,28]
TRPC3 4q27 Oxidant [19,20], DAG [7], VEGF [27] Oxidative stress-induced endothelial damage [19,20], essential
hypertension [66], idiopathic pulmonary arterial hypertension [67],
Angiogenesis [7,27,28]
TRPC4 13q13.1–q13.2 Oxidant [20], thrombin [16,17] ATP [17],
acetylcholine [17,21,13] store depletion
[16,17,18,21,42]
Oxidative stress-induced endothelial damage [19,20], endothelial
barrier dysfunction [16,17,18], endothelial-dependent vascular
relaxation [21]
TRPC5 Xq23 ATP [33], S-nitrosylation [33] Heart failure [68], essential hypertension [66]
TRPC6 11q21–22 Bradykinin [32], VEGF [7,27] DAG [7],
stretch [9,58,61]
Endothelial barrier dysfunction [7], angiogenesis [7,27,28],
idiopathic pulmonary arterial hypertension [67]
TRPM2 21q22.3 ADP-ribose, NAD, H2O2 [37,39,41] Oxidative stress-induced cell death? [37,39,41]
TRPM4 19q13.33 NO inactivated [35], PIP2, stretch [60] Decreased NO production? [35]
TRPM7 15q21 Oxidant [40], shear stress [56], PIP2 Angiogenesis? [6] Oxidative stress-induced cell death? [40]
TRPV1 17p13.3] Endocannabinoids [22,23,53] S-nitrosylation [33] NO production [22], Endothelium-dependent vascular
relaxation [22,23]
TRPV2 17p11.2 Stretch [59] Dystrophic cardiomyopathy [69]
TRPV4 12q24.1 Arachidonic acid [25], S-nitrosylation [33],
5′,6′-EETs [8], endocannabinoids [53], cell
swelling/shear stress [6,24,54]
Endothelium-dependent vascular relaxation [23,24,25],
flow-induced vascular response [6,24], BKca-coupled vascular
relaxation [12]
TRPP1–TRPP2 4q21–23 Shear stress [6] Flow-induced vascular response [6,29,30], NO production [64]
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[Ca2+]i, which is a crucial second messenger. The mode of TRP
channel activation is varied, and involves both capacitative and
noncapacitative mechanisms [[5], Table 1]. The capacitative
mechanism refers to the Ca2+ influx that is stimulated by
a reduction in the Ca2+ content in intracellular Ca2+ stores,
whereas the noncapacitative mechanism is independent of Ca2+
store depletion. Several signaling molecules, such as diacyl-
glycerol (DAG) [7] and 5,6-epoxyeicosatrienoic acid [8], are
found to activate specific TRP isoforms (TRPC3/6/7 and
TRPV4, respectively) in endothelial cells independent of store
depletion. Regardless of the activation mode, a rise in [Ca2+]i as
a result of TRP channel activation eventually leads to various
vascular responses, including changes in vascular tone,
alteration in vascular permeability, changes in blood coagula-Fig. 1. Schematic figure illustrating the linkage between specific endotheltion, vascular remodeling, and oxidative damage. In terms of
the second parameter, TRP channels are cation channels that
allow the influx of positive ions, such as Na+ and Ca2+, that
results in membrane depolarization. It has been demonstrated
that the activity of TRPC3, -C6, and -M4 contributes to
membrane depolarization in vascular smooth muscle cells [9–
11]. In contrast, the activation of another TRP channel, TRPV4,
is found to hyperpolarize the membrane in vascular smooth
muscle cells. In this instance, Ca2+ influx through TRPV4
channels stimulates Ca2+-sensitive K+ channels in the vascular
smooth muscle cells to cause subsequent smooth muscle
hyperpolarization [12]. It is likely that this type of coupling
between certain TRP isoforms and Ca2+-sensitive K+ channels
may also exist in endothelial cells, because the agonist-induced
Ca2+ influx in endothelial cells is usually accompanied byial cell TRP isoforms and possible vascular function and dysfunction.
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membrane potential that result from TRP channel activity may
ultimately alter the driving forces for Ca2+ entry to endothelial
cells, with hyperpolarization enhancing the Ca2+ influx and
depolarization reducing it [13]. Furthermore, changes in the
membrane potential of endothelial cells may also directly
spread to underlying vascular smooth muscle layers through
myoendothelial gap junctions, if these are present, and
subsequently influence the membrane potential of smooth
muscle cells, resulting in an alteration in vascular tone [6].
Because TRP channels play a critical role in endothelial
function, it is not surprising that the dysregulation of TRP
channel expression or activity may result in endothelial
dysfunction and vascular disease. Evidence shows that
TRPC1, -C4, and -C6 are associated with endothelial barrier
dysfunction [7,14–18]; TRPC3 and -C4 may contribute to
oxidative stress-induced endothelial damage [19,20]; TRPC4,
-V1, and -V4 are involved in the regulation and dysregulation of
endothelium-dependent vascular relaxation [21–25]; TRPC1,
-C3, and -C6 may participate in angiogenesis [7,26–28]; and
TRPV4 and the TRPP1–P2 complex may participate in flow-
induced vascular tone change [24,29,30]. In the following, we
summarize a large body of evidence that links TRP channels to
endothelial function and dysfunction (Table 1, Fig. 1).
3. Endothelial TRP channels and dysfunction in vascular
tone control
One of the most important functions of the endothelium is to
regulate vascular tone. Indeed, an impairment in vascular
relaxation is commonly used as an index for endothelial
dysfunction [2]. Vascular endothelial cells are exposed to
numerous endogenous vasoactive agents, such as ATP, hista-
mine, angiotensin II, and substance P, which are either contained
in circulating blood or released from vascular cells. These
compounds bind to their respective membrane receptors and
elicit a rise in endothelial [Ca2+]i, which in turn enhances the
production and release of a number of vasodilators, including
NO, prostacyclin, and endothelium-dependent hyperpolarizing
factors [2,31]. The basal release of NO from endothelial cells
appears to be a Ca2+-independent process, but a rise in [Ca2+]i
stimulates endothelial NO synthase, thereby increasing the
production and release of NO from endothelial cells [31].
Studies have demonstrated that vasoactive agents may act on
TRP channels to modulate endothelial [Ca2+]i levels (Table 1).
For example, TRPC4 is activated by acetylcholine in mouse
aortic endothelial cells [21]; TRPC6 is stimulated by bradykinin
in cultured mouse heart microvessel endothelial cells [32]; and
TRPC5 is activated by ATP in cultured bovine aortic endothelial
cells [33]. Note that although only a few TRP channel isoforms
have actually been shown to be activated by specific agonists in
endothelial cells, it is likely that future research will identify
more TRP isoforms that are responsive to vasoactive agonists,
because many TRP isoforms share similar activation mechan-
isms [6].
Because of the pivotal importance of TRP channels in
mediating Ca2+ influx in response to vasoactive agents, it is notsurprising that an alteration in TRP channel expression may
impair endothelium-dependent vascular relaxation. TRPC4
perhaps offers the best example of this. TRPC4 mediates
agonist-induced Ca2+ influx through both the capacitative [21]
and noncapacitative mechanisms [34]. In mice that lack TRPC4,
agonist-induced Ca2+ entry in aortic endothelial cells is
dramatically diminished [21], and as a consequence endothe-
lium-dependent vascular relaxation in response to vasoactive
agents ATP and acetylcholine is also impaired [21]. These data
provide compelling evidence that the diminished functioning of
TRPC4 may impair agonist-induced vascular relaxation. There
is also an indication that at least two other endothelial TRP
channels, TRPV1 and -V4, may be important in agonist-
induced vascular tone change [22–25]. In the isolated rat
mesenteric bed, the activation of TRPV1 either by cannabinoid
anandamine or capsaicin elicits an acute release of NO from
endothelial cells, an action that can be reduced by the TRPV1
receptor antagonists 5-iodoresiniferatoxin, SB 366791, and
capsazepine [22]. In human cerebral artery endothelial cells, the
stimulation of TRPV1 by 2-arachidonoyl-glycerol increases the
influx of Ca2+, which activates two important enzymes for
vascular dilation, namely, protein kinase G and protein kinase
A. This action is indicated by enhanced phosphorylation of
vasodilator-stimulated phosphoprotein [23], which is a selective
substrate for these two kinases. For TRPV4, it has been shown
that 4α-phorbol-12,13-didecanoate and arachidonic acid can
activate this channel in endothelial cells, causing endothelium-
dependent vascular relaxation in rat coronary and cerebral
arteries [24,25]. Note that although these results suggest that
TRPV1 and -V4 play an important role in the control of vascular
tone, it is yet to be demonstrated that the altered function of
these channels can directly impair agonist-induced vascular
relaxation. However, there is evidence that reduced TRPC4
activity can impair flow-induced vascular relaxation, an issue
that will be further discussed later.
As has been mentioned, the malfunction of TRP channels
may impair Ca2+ influx, causing a reduction in NO bioavail-
ability and the subsequent impairment in vascular relaxation.
Interestingly, recent studies suggest that NO itself may
modulate TRP channels activity through feedback mechanisms.
NO may activate multiple TRP isoforms, including TRPC5,
-V1, -V3, and -V4, by cysteine S-nitrosylation [33]. However,
NO and its downstream signal molecules cGMP and protein
kinase G can also inhibit several TRP isoforms in endothelial
cells, such as TRPC3, -C6, -M4, in a negative feedback manner
[35,36]. These feedback mechanisms may act as NO sensors
that allow endothelial NO levels to be finely regulated. The
dysregulation of these pathways may therefore disturb the NO
balance, resulting in endothelial dysfunction.
4. Endothelial TRP channels and oxidative stress
Oxidative stress describes the cell injury that results from the
increased formation of reactive oxygen species (ROS) and/or
the decreased antioxidant reserves. The physiological produc-
tion of ROS is necessary for the maintenance of cell
homeostasis, but the excessive production of ROS results in
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ROS that are released from neutrophils, macrophages, and
vascular smooth muscle cells [2,38]. Moreover, endothelial
cells are themselves generators of ROS [2,38]. The main ROS
that are produced are superoxide anions, hydroxyl radicals,
peroxynitrite, and H2O2. ROS may arise from the activity of
NADPH oxidase, xanthine/xanthine oxidase, uncoupled NO
synthase, and mitochondrial respiration. In pathological states
or stress conditions, such as inflammation, hyperglycemia and
ischemia/reperfusion, ROS are produced in excessive amounts
[2,38]. These excess ROS react with endothelial macromole-
cules to cause extensive damage to the structure and function of
endothelial cells. For example, superoxide anions reduce the
bioavailability of NO by scavenging NO and inhibiting the
expression of endothelial NO synthase, which results in the
impairment of endothelium-dependent vascular relaxation and
abnormal leukocyte adhesion and platelet aggregation onto the
surface of endothelial cells [2,38]. Furthermore, the over-
production of ROS also induces endothelium-dependent
contractions [2]. Such ROS-induced endothelial dysfunction
may eventually contribute to the pathogenesis of many vascular
diseases, including atherosclerosis, hypertension, and heart
failure [38].
ROS-induced endothelial dysfunction is often preceded by
an alteration in endothelial [Ca2+]i, which may result from ROS
action on plasma membrane channels, InsP3-receptors, endo-
plasmic reticulum Ca2+-ATPase, or other Ca2+ signaling
pathways [6,20]. Recent evidence indicates that TRP channels
are important targets for ROS [19,20,39,40]. These ROS-
sensitive TRP channels may potentially act as endothelial cell
sensors for oxidative stress, an interaction that may have very
significant physiological and pathological consequences [6,20].
Furthermore, the ability to downregulate these channels may be
a means of protecting endothelial cells from oxidative stress-
induced cell injury.
Two TRPC channels, TRPC3 and -C4, are activated by
oxidative stress. Balzer et al. [19] show that the oxidant tert-
butylhydroperoxide activates TRP-like cation conductance in
porcine aortic endothelial cells. The expression of an N-terminal
fragment of human TRPC3, but not of a C-terminal fragment,
abolishes the oxidant-induced cation current, suggesting that
TRPC3 is a component of oxidant-activated cation channels in
endothelial cells. A follow-up study by the same research group
demonstrates that the oxidant-activated TRPC3 cation con-
ductance in TRPC3-overexpressing HEK cells and porcine
aortic endothelial cells is inhibited by dominant negative
mutants of TRPC4 [20]. The authors conclude that TRPC3
and -C4 may form redox-sensitive heteromeric channels that are
the molecular basis of oxidant-activated cation channels in
porcine aortic endothelial cells [20].
TRPM2 and -M7 are also activated by oxidative stress
[37,39,40] and are both expressed in endothelial cells [6], but
there is still a lack of evidence of the functional role of these
channels in endothelial cells. However, in several other cell
types, TRPM2 and -M7 play a role in ROS-induced cell injury.
For instance, TRPM2-transfected HEK293 cells display an
oxidative stress-induced [Ca2+]i rise and an increased suscept-ibility to cell death [39]. In rat insulinoma RIN-5F cells, the
suppression of TRPM2 expression with antisense oligonucleo-
tides significantly reduces ROS-induced cell death [39]. In
monocytic cell line U937-ecoR, oxidative stress increases the
expression level of TRPM2 with an associated decrease in cell
viability, and the suppression of endogenous TRPM2 either by
RNA interference or dominant negative splice variant reduces
the cell death that is induced by H2O2 [41]. In cortical neurons,
the suppression of TRPM7 expression with RNA interference
blocks TRPM7-like currents, anoxic Ca2+ uptake, and anoxic
neuronal cell death [40]. Collectively, these data suggest that
TRPM2 and -M7 have an important functional role in oxidative
stress-induced cell injury. However, future studies are needed to
determine whether these two channels also play a role in
oxidative stress-induced endothelial damage.
5. TRP channels and endothelial barrier dysfunction
The endothelial cell layer forms a semi-permeable dynamic
barrier between the vascular space of blood vessels and
underlying tissues. Endothelial cells tightly adhere to each
other, which helps to maintain the integrity of the vessel wall and
control the passage of plasma proteins and solutes. The
permeability of the endothelial barrier is balanced by the
contraction force of the endothelial cells and the adhesive force
that holds the cells in a flattened state [16]. Therefore, an
increase in the contraction force or decrease in the adhesive force
enlarges the interendothelial gap, resulting in the loss of the
selective vascular barrier to circulating macromolecules [16].
Inflammatory cytokines, viruses, and growth factors act on
the endothelial barrier to initiate a cascade of events that lead to
vascular leakage and vascular edema [16]. One of the early
events in this signaling cascade is a rise in endothelial [Ca2+]i.
After binding to their respective receptors, growth factors
activate phospholipase C-γ and inflammatory mediators
stimulate phospholipase C-β. The activity of phospholipase C
produces InsP3, causing subsequent release of stored Ca
2+,
which in turn stimulates capacitative Ca2+ influx [16]. The rise
in [Ca2+]i then activates key signaling pathways, which results
in myosin light chain-dependent endothelial cell contraction,
actin polymerization, and the disassembly of vascular endothe-
lial cadherin at the adherens junctions [16]. These events
eventually lead to endothelial barrier dysfunction [16].
The rise in [Ca2+]i is a requisite for endothelial barrier
dysfunction [16]. Several TRP channels, including TRPC1,
-C4, and -C6, are implicated in endothelial barrier dysfunction.
For instance, increasing the expression of TRPC1 either by
challenging endothelial cells with tumor necrosis factor-α or by
TRPC1-cDNA transfection results in excessive Ca2+ influx,
which exaggerates the thrombin-induced increase in actin-stress
fiber formation and leads to endothelial barrier dysfunction
[14]. Thrombin is an inflammatory mediator that activates
TRPC1. The resultant Ca2+ influx in turn stimulates TRPC1
protein synthesis, which causes further Ca2+ influx to form a
positive feed-forward loop [15]. The excessive Ca2+ influx that
is generated from this positive feed-forward loop is suggested to
be a cause of endothelial barrier dysfunction [15].
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endothelial barrier function and dysfunction. The activation of
TRPC4 requires protein 4.1, which tethers the channel to the
membrane skeleton and forms the gating mechanism that is
required for Ca2+ permeation [18]. Like TRPC1, TRPC4 also
contributes to capacitative Ca2+ influx [16–18]. There is
evidence that TRPC4 and -C1 actually form heteromultimeric
channels that may be the molecular basis of a capacitative Ca2+
channel in endothelial cells [42]. It is known that excessive
capacitative Ca2+ influx in endothelial cells, which is likely due
to the activity of TRPC1 and -C4, triggers cytoskeletal
reorganization, eventually leading to the disruption of the
endothelial barrier [16,43]. In contrast, the suppression of
capacitative Ca2+ influx through the deletion of the TRPC4
gene can blunt thrombin-induced actin stress fiber formation
and cell retraction [16], thereby reducing the thrombin-induced
increase in vascular permeability [16].
TRPC6 may also be involved in endothelial barrier
dysfunction. In frog mesenteric microvessels, vascular endothe-
lial growth factor (VEGF)-induced increases in vascular
permeability can be mimicked by 1-oleoyl-2-acetylglycerol,
an activator of the TRPC3/6/7 subfamily of channels [7].
Furthermore, flufenamic acid, which activates TRPC6 but
inhibits -C3 and -C7, enhances the VEGF-induced increase in
vascular permeability. These data suggest that TRPC6 has a role
in VEGF-mediated vascular barrier dysfunction [7].
6. Endothelial TRP channels and the perturbed angiogenic
process
Angiogenesis is a process of new vessel formation during
which vascular growth factors, such as VEGF, basic fibroblast
growth factor (bFGF), platelet-derived growth factor (PDGF),
and transforming growth factors, increase vascular permeabil-
ity, facilitate the breakdown of the extracellular matrix, and
stimulate the migration and proliferation of endothelial cells
[44]. Angiogenesis occurs under physiological conditions, such
as vessel growth and repair, and pathological conditions, such
as neovascularization at the sites of tumors. Atherosclerosis can
also be considered to be an angiogenesis-associated disease,
because many studies have shown that intimal neovasculariza-
tion is associated with plaque development and instability [45].
Endothelial cells play an essential role in the angiogenic
process. Endothelial dysfunction with reduced NO bioavail-
ability may impair normal angiogenesis in physiological
conditions, thus delaying vessel repair after damage and
causing insufficient neovascularization at ischemic sites [46].
A dysfunctional endothelium may also contribute to intimal
neovascularization in atherosclerotic plaques [46].
TRP channels may affect the angiogenic process through
several mechanisms. First, angiogenic growth factors such as
VEGF and bFGF may activate TRP channels, causing a
subsequent rise in endothelial [Ca2+]i, which modulates the
signal transduction pathways and leads to angiogenesis [6,31].
In this aspect, it has been found that TRPC1 is involved in
bFGF-induced Ca2+ influx in bovine aortic endothelial cells
[26]; TRPC6 contributes to VEGF-induced Ca2+ influx in frogmesenteric microvessels endothelial cells [7]; and TRPC3 and
-C6 mediate VEGF-induced Ca2+ influx in human microvas-
cular endothelial cells in vivo [27]. Second, Ca2+ influx through
TRP channels may stimulate endothelial cells to produce and
release the angiogenic growth factors VEGF and PDGF [6,28],
which consequently stimulate angiogenesis. Third, some TRP
channels, including TRPM6 and -M7, allow the influx of Mg2+,
which is an essential player in endothelial cell proliferation and
angiogenesis [6,31,47]. It is possible that TRP channel-
mediated [Mg2+]i influx in response to mitogenic agents may
modulate the downstream signal transduction pathways, leading
to angiogenic development [6,31,47]. Note that although a
substantial amount of data supports the role of TRP in
angiogenesis, there is still no direct evidence to show that the
dysfunction of endothelial TRP channels can indeed impair
normal vessel growth/repair or promote neovascularization
during atherosclerotic progression.
7. TRP channels, mechanical responses, and endothelial
dysfunction
Blood flow exerts a viscous drag, or shear stress, on the
surface of endothelial cells that are aligned in the direction of
flow [48]. Endothelial cells exhibit diverse biochemical and
physiological responses to shear stress. A high shear flow has
been found to increase the endothelial release of NO and
prostacyclin; inhibit leukocyte binding and chemoattractant
protein expression on endothelial cell surface; reduce the release
of growth factors from endothelial cells, thus inhibiting the
proliferation of smooth muscle cells; and exert an anti-apoptotic
effect on endothelial cells, thus preventing the occurrence of
artery lesions [48]. In contrast, a low shear stress and a reversal
in the direction of flow may lead to endothelial dysfunction.
Manifestations of dysfunctional endothelium can be readily
observed in certain areas of the arterial tree, such as branch
points, that experience a low mean shear stress and flow reversal
[49].
Some of the shear stress-induced responses, such as the
regulation of gene expression and the release of NO, are at least
partly related to a rise in [Ca2+]i [50,51], in which flow-sensitive
Ca2+ channels may play a key role [6,52]. Several endothelial
TRP channels, including TRPV4 and the TRPP1–P2 complex,
are activated by shear stress [6,53,54]. The dysfunction or
dysregulation of these channels may impair flow-induced
vascular relaxation. Using a pressure myograph technique,
Kohler et al. found that the inhibition of endothelial TRPV4
channels, either with ruthenium red or arachidonyl trifluor-
omethyl ketone, abolishes the flow-induced vascular relaxation
in rat carotid arteries and arteria gracilis [24]. These experiments
provide the first evidence that the dysfunction of TRPV4
channels in endothelial cells may impair flow-induced vascular
relaxation.
The TRPP1–P2 complex mediates flow-induced Ca2+ influx
in renal epithelial cells [55]. Nauli et al. propose that TRPP1 and
-P2 physically interact with each other to form a mechanosensor
that detects fluid flow in renal epithelial cells. Within the
complex, TRPP1 serves as a sensor to transduce the flow
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and -P2 are both expressed in vascular endothelial cells [6], and
evidence suggests that the malfunction of endothelial TRPP1
and -P2 may impair the regulation of NO synthase, resulting in
endothelial dysfunction that may contribute to the progress of
the common genetic autosomal dominant polycystic kidney
disease (ADPKD) [29,30].
A recent study also shows that TRPM7 is sensitive to flow
shear stress, and thus plays a role in pathological responses to
vessel wall injury [56]. Oancea et al. found that the exposure of
vascular smooth muscle cells to flow shear stress facilitates the
translocation of TRPM7 proteins to the plasma membrane,
which results in an increase in the whole-cell TRPM7 currents.
The authors propose that this increased TRPM7 activity may
cause smooth muscle cell injury in areas in which smooth
muscle cells are exposed to flow, such as in atherosclerotic
regions [56]. However, it is not clear whether TRPM7 in
endothelial cells has a similar function.
In addition to shear stress-activated channels, endothelial
cells also express other mechanosensitive TRP channels,
including those activated by membrane stretch directly and
those activated by stretch indirectly through cytosolic signaling
molecules. The former group includes TRPC1, -C6, and -V2
[57–59], and the latter group includes TRPC6 and -M4. In
indirect pathways, it has been shown that TRPM4 can be
activated through the mechanosensitive production of DAG or
PKC [60], whereas TRPC6 is activated through DAG [9,61].
Interestingly, intravascular pressure can activate TRPC6 by
both direct and indirect pathways. Regardless of the details of
their activation mechanisms, these mechanosensitive TRP
channels are expected to be activated by the pulsatile stretching
of the endothelial cell plasma membrane during cardiac cycles.
The malfunction of these channels may result in the dysregula-
tion of vascular tone.
8. Endothelial TRP channels and vascular diseases
Endothelial dysfunction is a multifaceted disorder that is
associated with many cardiovascular diseases, including
hypertension, atherosclerosis, heart and renal failure, coronary
syndrome, thrombosis, diabetes, obesity, inflammation, and
hypercholesterolemia [2]. Taking hypertension as an example,
endothelium dysfunction precedes the onset of high arterial
blood pressure in many hypertensive patients [62], who display
an increased production of ROS, a decreased availability of NO,
and an augmented production of endothelium-derived contract-
ing factors, all of which adversely affect the control of vascular
tone [2]. As has been described, endothelial dysfunction may be
caused by the malfunction of TRP channels, and it is therefore
tempting to suggest that the malfunction of endothelial TRP
channels may be a causative factor that contributes to vascular
diseases.
Perhaps the strongest evidence for the causative role of
endothelial TRP channels in vascular diseases is the TRPP
mutations in ADPKD. ADPKD patients present an impaired
endothelium-dependent relaxation to acetylcholine in resistance
vessels [63]. Moreover, a frequent polymorphism of endothelialNO synthase, Glu298Asp, has been found to be associated with
renal disease progression in ADPKD patients [64]. In animal
studies, TRPP1 heterozygous mice (TRPP1+/−) also display an
impairment in endothelium-dependent vascular relaxation, and
TRPP1 knockout mice display the pathogenesis of vascular
fragility, edema, and localized hemorrhages [29,65]. Collec-
tively, these data suggest that the malfunction of endothelial
TRPP1 and -P2 impairs the complex regulation of endothelial
NO synthase, which results in endothelial dysfunction and
contributes to the progression of ADPKD [30].
In addition to TRPP1–P2 complex, the dysfunction or
dysregulation of other TRP channels may also contribute to
cardiovascular diseases. For example, the expression level of
TRPC3 and -C5 in monocytes is increased in patients with
essential hypertension [66]; there is an increased expression of
TRPC3 and -C6 in pulmonary artery smooth muscle cells in
patients with idiopathic pulmonary arterial hypertension [67];
and the expression level of TRPC5 channels is abnormally
elevated in the failing human heart [68]. In addition, the
overexpression of TRPV2 has been suggested to be responsible
for cardiac muscle degeneration in patients with dystrophic
cardiomyopathy [69]. Interestingly, a recent study has explored
the therapeutic potential of targeting TRPC1 and finds that
inhibiting TRPC1 with a blocking antibody results in a
significant reduction in neointimal growth in the human
saphenous vein [70]. These data suggest the possibility of
targeting TRPC1 for the therapeutic treatment of occlusive
vascular diseases such as atherosclerosis [70]. However, note
that in most of the aforementioned cases, the TRP channels that
reside in vascular smooth muscle cells or cardiac myocytes are
believed to be the culprits, and it is not clear whether the
dysfunction of endothelial TRP channels may also contribute to
the pathogenesis of these diseases. Nevertheless, due to the
close association between cardiovascular diseases and endothe-
lial dysfunction, it would not be a surprise if future studies find a
link between these diseases and endothelial TRP dysfunction.
9. Concluding remarks
The dysfunction and dysregulation of endothelial TRP
channels are suggested to result in excessive oxidative damage,
decreased NO availability, the disruption of the endothelial
barrier, and the progression of angiogenesis-associated diseases
(Table 1). However, the field of TRP channels is rapidly
evolving, and many areas of uncertainty remain. Direct links
between TRP channels and endothelial dysfunction have been
convincingly demonstrated in only a very small number of
cases, and therefore the roles of many TRP channels in
endothelial dysfunction and vascular diseases remain largely
speculative. Obviously, we are still in the initial stage of
considering endothelial TRP channels as targets for novel
therapeutic intervention, and further study is needed to achieve
definite and detailed answers regarding the role of different TRP
isoforms in endothelial dysfunction. Because of the lack of
specific pharmacological inhibitors for many TRP channel
isoforms, other molecular biological techniques, such as gene
knockout mice and small-interference RNA-mediated gene-
913H.-Y. Kwan et al. / Biochimica et Biophysica Acta 1772 (2007) 907–914silencing technology, may be particularly useful for the
elucidation of the role of TRP channels in endothelial
dysfunction. Genetic linkage analysis in patients with ion
channelopathy should further help to reveal the pathological
consequences of TRP channel dysfunction and dysregulation.
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